KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Resmed (RMD) over the last 14 years, with Q4 2025 value amounting to $146.0 million.

  • Resmed's Shares Outstanding (Weighted Average) fell 56.05% to $146.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $146.0 million, marking a year-over-year decrease of 56.05%. This contributed to the annual value of $146.7 million for FY2025, which is 20.75% down from last year.
  • Latest data reveals that Resmed reported Shares Outstanding (Weighted Average) of $146.0 million as of Q4 2025, which was down 56.05% from $146.2 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Shares Outstanding (Weighted Average) registered a high of $147.1 million during Q4 2023, and its lowest value of $145.3 million during Q2 2021.
  • Over the past 5 years, Resmed's median Shares Outstanding (Weighted Average) value was $146.7 million (recorded in 2022), while the average stood at $146.5 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 67.55% in 2021, then tumbled by 56.05% in 2025.
  • Quarter analysis of 5 years shows Resmed's Shares Outstanding (Weighted Average) stood at $146.0 million in 2021, then increased by 0.49% to $146.7 million in 2022, then rose by 0.29% to $147.1 million in 2023, then dropped by 0.2% to $146.8 million in 2024, then fell by 0.56% to $146.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $146.0 million for Q4 2025, versus $146.2 million for Q3 2025 and $146.7 million for Q2 2025.